Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 79

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers

Singh, Deo R., Dalton, Michael P., Cho, Ellen E., Pribadi, Marsha P., Zak, Taylor J., Šeflová, Jaroslava, Makarewich, Catherine A., Olson, Eric N., Robia, Seth L. · 2019 · Journal of Molecular Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jmb.2019.07.037

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 62

  1. Tada, 1979, Mechanism of the stimulation of Ca2+−dependent ATPase of cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase. Role of the 22,000-Dalton protein, J. Biol. Chem., 254, 319, 10.1016/S0021-9258(17)37920-6 · DOI · Paper page
  2. Odermatt, 1997, Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: absence of structural mutations in five patients with Brody disease, Genomics, 45, 541, 10.1006/geno.1997.4967 · DOI · Paper page
  3. Anderson, D. M., Makarewich, C. A., Anderson, K. M., Shelton, J. M., Bezprozvannaya, S., Bassel-Duby, R., and Olson, E. N. (2016) Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides, Sci Signal 9, ra119. · DOI · Paper page
  4. Nelson, 2016, A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle, Science, 351, 271, 10.1126/science.aad4076 · DOI · Paper page
  5. Geering, 2003, FXYD proteins: new tissue- and isoform-specific regulators of Na,K-ATPase, Ann. N. Y. Acad. Sci., 986, 388, 10.1111/j.1749-6632.2003.tb07219.x · DOI
  6. Pirkmajer, 2017, Early vertebrate origin and diversification of small transmembrane regulators of cellular ion transport, J. Physiol., 595, 4611, 10.1113/JP274254 · DOI
  7. Makarewich, 2018, The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy, Elife, 7
  8. Ceholski, 2012, Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy, J. Biol. Chem., 287, 16521, 10.1074/jbc.M112.360859 · DOI · Paper page
  9. Negash, 2000, Phospholamban remains associated with the Ca2+− and Mg2+−dependent ATPase following phosphorylation by cAMP-dependent protein kinase, The Biochemical journal, 351, 195, 10.1042/bj3510195 · doi:10.1042/bj3510195
  10. Tada, 1983, Effects of phospholamban phosphorylation catalyzed by adenosine 3′:5′-monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum, J. Mol. Cell. Cardiol., 15, 335, 10.1016/0022-2828(83)91345-7 · doi:10.1016/0022-2828(83)91345-7
  11. Louis, 1987, Phospholamban stoichiometry in canine cardiac muscle sarcoplasmic reticulum, Neurochem. Res., 12, 937, 10.1007/BF00966316 · doi:10.1007/bf00966316
  12. Colyer, 1991, Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban, J. Biol. Chem., 266, 17486, 10.1016/S0021-9258(19)47398-5 · DOI
  13. Ferrington, 2002, Comparable levels of ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum, Biochemistry, 41, 13289, 10.1021/bi026407t · DOI · Paper page
  14. Kadambi, 1996, Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice, J. Clin. Invest., 97, 533, 10.1172/JCI118446 · DOI · Paper page
  15. Autry, 1997, Functional co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation, J. Biol. Chem., 272, 15872, 10.1074/jbc.272.25.15872 · DOI · Paper page
  16. Kelly, 2008, Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells, J. Biol. Chem., 283, 12202, 10.1074/jbc.M707590200 · doi:10.1074/jbc.m707590200
  17. Kimura, 1997, Phospholamban inhibitory function is activated by depolymerization, J. Biol. Chem., 272, 15061, 10.1074/jbc.272.24.15061 · DOI · Paper page
  18. Zvaritch, 2000, The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility, J. Biol. Chem., 275, 14985, 10.1074/jbc.275.20.14985 · DOI
  19. Reddy, 1999, Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study, Biochemistry, 38, 3954, 10.1021/bi981795d · doi:10.1021/bi981795d
  20. Chen, 2007, Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase a and by anti-phospholamban monoclonal antibody 2D12, J. Biol. Chem., 282, 20968, 10.1074/jbc.M703516200 · doi:10.1074/jbc.m703516200
  21. Cornea, 1997, Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers, Biochemistry, 36, 2960, 10.1021/bi961955q · DOI · Paper page
  22. Hou, 2008, Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex, J. Biol. Chem., 283, 28996, 10.1074/jbc.M804782200 · doi:10.1074/jbc.m804782200
  23. Abrol, 2015, Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban, J. Biol. Chem., 290, 7130, 10.1074/jbc.M114.630319 · doi:10.1074/jbc.m114.630319
  24. Ha, 2011, Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase a, Proc. Natl. Acad. Sci. U. S. A., 108, 2735, 10.1073/pnas.1013987108 · DOI
  25. Cornea, 2000, Reexamination of the role of the leucine/isoleucine zipper residues of phospholamban in inhibition of the Ca2+ pump of cardiac sarcoplasmic reticulum, J. Biol. Chem., 275, 41487, 10.1074/jbc.M008195200 · doi:10.1074/jbc.m008195200
  26. Zhai, 2000, Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo, J. Biol. Chem., 275, 10538, 10.1074/jbc.275.14.10538 · DOI
  27. Abrol, 2014, Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex, J. Biol. Chem., 289, 25855, 10.1074/jbc.M114.562579 · DOI
  28. Periasamy, 2008, Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology, Cardiovasc. Res., 77, 265, 10.1093/cvr/cvm056 · DOI · Paper page
  29. Hasenfuss, 2002, Calcium cycling in congestive heart failure, J. Mol. Cell. Cardiol., 34, 951, 10.1006/jmcc.2002.2037 · DOI · Paper page
  30. Medin, 2007, Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation, Eur. J. Heart Fail., 9, 37, 10.1016/j.ejheart.2006.04.007 · DOI
  31. Haghighi, 2006, A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy, Proc. Natl. Acad. Sci. U. S. A., 103, 1388, 10.1073/pnas.0510519103 · DOI · Paper page
  32. Schmitt, 2003, Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban, Science, 299, 1410, 10.1126/science.1081578 · DOI · Paper page
  33. Minamisawa, 2003, Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy, Biochem. Biophys. Res. Commun., 304, 1, 10.1016/S0006-291X(03)00526-6 · DOI
  34. Kranias, 2012, Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome, Circ. Res., 110, 1646, 10.1161/CIRCRESAHA.111.259754 · DOI · Paper page
  35. Kawase, 2008, The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases, Nat Clin Pract Cardiovasc Med, 5, 554, 10.1038/ncpcardio1301 · DOI
  36. Hoshijima, 2005, Gene therapy targeted at calcium handling as an approach to the treatment of heart failure, Pharmacol. Ther., 105, 211, 10.1016/j.pharmthera.2004.10.006 · DOI
  37. Asahi, 2003, Sarcolipin regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholamban, Proc. Natl. Acad. Sci. U. S. A., 100, 5040, 10.1073/pnas.0330962100 · DOI · Paper page
  38. Akin, 2013, The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum, J. Biol. Chem., 288, 30181, 10.1074/jbc.M113.501585 · DOI · Paper page
  39. Bidwell, 2011, Phospholamban binds with differential affinity to calcium pump conformers, J. Biol. Chem., 286, 35044, 10.1074/jbc.M111.266759 · DOI · Paper page
  40. Glaves, 2019, The Phospholamban Pentamer alters function of the sarcoplasmic reticulum calcium pump SERCA, Biophys. J., 116, 633, 10.1016/j.bpj.2019.01.013 · DOI
  41. Hou, 2010, Relative affinity of calcium pump isoforms for phospholamban quantified by fluorescence resonance energy transfer, J. Mol. Biol., 402, 210, 10.1016/j.jmb.2010.07.023 · doi:10.1016/j.jmb.2010.07.023
  42. King, 2016, Fully quantified spectral imaging reveals in vivo membrane protein interactions, Integr Biol (Camb), 8, 216, 10.1039/c5ib00202h · DOI
  43. Sarabipour, 2016, Mechanism of FGF receptor dimerization and activation, Nat. Commun., 7, 10262, 10.1038/ncomms10262 · DOI · Paper page
  44. Singh, 2017, Intracellular domain contacts contribute to Ecadherin constitutive dimerization in the plasma membrane, J. Mol. Biol., 429, 2231, 10.1016/j.jmb.2017.05.020 · DOI
  45. Singh, 2018, The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures, Commun Biol, 1, 15, 10.1038/s42003-018-0017-7 · DOI
  46. Koushik, 2006, Cerulean, Venus, and VenusY67C FRET reference standards, Biophys. J., 91, L99, 10.1529/biophysj.106.096206 · doi:10.1529/biophysj.106.096206
  47. Autry, 2011, Oligomeric interactions of sarcolipin and the ca-ATPase, J. Biol. Chem., 286, 31697, 10.1074/jbc.M111.246843 · doi:10.1074/jbc.m111.246843
  48. Verardi, 2011, Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method, Proc. Natl. Acad. Sci. U. S. A., 108, 9101, 10.1073/pnas.1016535108 · DOI · Paper page
  49. Abu-Baker, 2006, Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study, Biochemistry, 45, 13312, 10.1021/bi0614028 · doi:10.1021/bi0614028
  50. Clayton, 2005, The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces, Biochemistry, 44, 17016, 10.1021/bi0511383 · doi:10.1021/bi0511383
  51. Kirby, 2004, Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum ca-ATPase, Biochemistry, 43, 5842, 10.1021/bi035749b · doi:10.1021/bi035749b
  52. Zamoon, 2003, NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles, Biophys. J., 85, 2589, 10.1016/S0006-3495(03)74681-5 · DOI
  53. Blackwell, 2016, Cardiac calcium ATPase dimerization measured by cross-linking and fluorescence energy transfer, Biophys. J., 111, 1192, 10.1016/j.bpj.2016.08.005 · DOI
  54. Pollesello, 1999, Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer, Biophys. J., 76, 1784, 10.1016/S0006-3495(99)77339-X · DOI
  55. Robia, 2005, Phospholamban pentamer quaternary conformation determined by in-gel fluorescence anisotropy, Biochemistry, 44, 4302, 10.1021/bi0478446 · DOI
  56. Traaseth, 2007, Spectroscopic validation of the pentameric structure of phospholamban, Proc. Natl. Acad. Sci. U. S. A., 104, 14676, 10.1073/pnas.0701016104 · DOI · Paper page
  57. Li, 1999, A fluorescence energy transfer method for analyzing protein oligomeric structure: application to phospholamban, Biophys. J., 76, 2587, 10.1016/S0006-3495(99)77411-4 · DOI
  58. Robia, 2007, Forster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex, Circ. Res., 101, 1123, 10.1161/CIRCRESAHA.107.159947 · doi:10.1161/circresaha.107.159947
  59. Zal, 2004, Photobleaching-corrected FRET efficiency imaging of live cells, Biophys. J., 86, 3923, 10.1529/biophysj.103.022087 · DOI · Paper page
  60. Förster, 1948, Intermolecular energy migration and fluorescence, Ann. Phys. (Leipzig), 2, 55, 10.1002/andp.19484370105 · DOI · Paper page
  61. Sarkar, 2009, Photophysical properties of cerulean and Venus fluorescent proteins, J. Biomed. Opt., 14, 10.1117/1.3156842 · doi:10.1117/1.3156842
  62. Bidwell, 2016, Calcium uptake in crude tissue preparation, Methods Mol. Biol., 1377, 161, 10.1007/978-1-4939-3179-8_16 · doi:10.1007/978-1-4939-3179-8_16

Cited by

See all 79

Metadata

Authors
Singh, D. R., Dalton, M. P., Cho, E. E., Pribadi, M. P., Zak, T. J., Šeflová, J., Makarewich, C. A., Olson, E. N., & Robia, S. L.
Venue
Journal of Molecular Biology
Publisher
Elsevier BV
Published
2019-11
Volume
431
Issue
22
Pages
4429-4443
ISSN
0022-2836
Cited by
79
References
2
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Institutes of Health
  • Fondation Leducq

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers. https://app.cochat.ai/papers/10.1016/j.jmb.2019.07.037
The paper
Singh, D. R., Dalton, M. P., Cho, E. E., Pribadi, M. P., Zak, T. J., Šeflová, J., Makarewich, C. A., Olson, E. N., & Robia, S. L. (2019). Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers. Journal of Molecular Biology. https://doi.org/10.1016/j.jmb.2019.07.037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.